期刊文献+

咪唑克生对实验性变态反应性脑脊髓炎干预作用的初步观察 被引量:15

Preliminary study on interventive effect of Idazoxan on experimental allergic encepha- lomyelitis in Lewis rats
下载PDF
导出
摘要 目的:探讨不同剂量的咪唑克生(Ida)对Lewis大鼠实验性变态反应性脑脊髓炎(EAE)的影响。方法:采用豚鼠全脊髓匀浆(GPSCH)脚垫皮下注射,免疫Lewis大鼠复制EAE模型,采用量化评分法, 比较不同剂量组咪唑克生对EAE发病率、潜伏期、临床症状和组织学的影响。结果:对照组的发病率为 85.7%(6/7),潜伏期为(11.2±0.45)d。低剂量咪唑克生(2 mg/kg)可降低发病率37.5%(3/8),明显延长潜伏期[(13.05±0.58)d,P<0.05],减轻其临床症状和中枢神经系统(CNS)炎症细胞浸润(P< 0.05),而高剂量咪唑克生(16 mg/kg)对EAE的潜伏期、临床症状和CNS炎症细胞浸润均无影响。结论: 低剂量咪唑克生可减轻Lewis大鼠EAE的炎症细胞浸润、脱髓鞘改变及临床症状,对EAE的发病具有干预(保护)作用。推测这可能与CNS内咪唑啉2受体有关。 Objective:To investigate the effect of idazoxan with different doses on experimental allergic encephalomyelitis (EAE) in Lewis rats. Methods:The EAE in Lewis rats was induced by giving hypodermal injections in feet with spinal cords homogenate of guinea pigs (GPSCH); The histological changes were observed under light microscope, then changes of incidence rate, latency, clinical symptoms and histology of EAE which were effected by idazoxan with different doses were compared by method of quantization. Results:The EAE in Lewis rats of contral group hadanincidence of 85.7%(6/7)) a latency of (11.2±0.45)d. Idazoxan with low dosage(2 mg/kg) could significantly decrease incidence rate of 37.5%(3/8), and lengthen the latency(13.05 ± 0.58d P〈0.05), ameliorate the clinical severity and infiltration of inflammatory cell in CNS of EAE(F〈 0.05). However, Idazoxanwith high dosage (16 mg/kg) had no effect.Conclusion:Idazoxan with low dosage (2 mg/kg) can relieve the clinical severity and ameliorate inflammatory cell infiltration and demyelination of EAE induced by GPSCH in Leiws rats. It may have protective effect on EAE. It is presumed that the effect is,related to imidazoline 2 receptor in CNS.
出处 《温州医学院学报》 CAS 2006年第1期1-5,共5页 Journal of Wenzhou Medical College
基金 国家自然科学基金资助项目(30470611) 浙江省自然科学基金资助项目(Y30470611)。
关键词 脑脊髓炎 自身免疫性 实验性 咪唑克生 咪唑啉受体 劝物实验 encephalomyelitis autoimmune idazoxan imidazoline receptor animal experiment
  • 相关文献

参考文献9

  • 1Maiese K,Pek L,Berger SB,Reis DJ.Reduction in focal cerebral ischemia by agents acting at imidazole receptors[J].J Cereb Blood Flow Metab,1992,12(1) :53-63.
  • 2Reis DJ,Regunathan S,Golanov EV,et al.Protection of focal ischemic infarction by rilmenidine in the animal:evidence that interactions with central imidazoline receptors may be neuroprotective[J].Am J Cardiol,1994,74(13):25A-30A.
  • 3Kono DH,Urban JL,Horvath S J,et al.Two minor determi nants of myelin basic protein induce experimental allergic en cephalomyelitis in SJL/J mice[J].J Exp Med,1988,168(1):213-227.
  • 4Okuda Y,Sakoda S,Fujimura H,et al.IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte gluco protein 35-55 induced experimental autoimmune encephalomyelitis[J].J Neuroimmunol,1999,101 (2):188-196.
  • 5Goverman J,Perchellet A,Huseby ES.The role of CD8(+) T cells in multiple sclerosis and its animal models[J].Curr Drug Targets Inflamm Allergy ,2005,4(2):239-245.
  • 6Ruggiero DA,Regunathan S,Wang H,et al.Immunocytochemical localization of an imidazoline receptor protein in the central nervous system[J].Brain Res,1998,780(2):270-293.
  • 7Llado J,Esteban S,Garcia-Sevilla JA.The alpha 2-adrenoceptor antagonist idazoxan is an agonist at 5-HT1A autoreceptors modulating serotonin synthesis in the rat brain in vivo[J].Neurosci Lett,1996,218(2):111-114.
  • 8White SR,Black PC,Samathanam GK,et al.Prazosin suppresses development of axonal damage in rats inoculated for experimental allergic encephalomyelitis[J].J Neuroimmunol,1992,39(3):211-218.
  • 9Freire-Garabal M,Nunez MJ,Balboa J,et al.Administration of the 5-hydroxytryptamine(1A) receptor antagonist WAY 100635 sup-presses acute experimental allergic encepha lomyelitis in Lewis rats[J].Neurosci Lett ,2003,342(1-2):33-36.

同被引文献114

引证文献15

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部